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Interrelationship between cardiac output and vascular resistance as
determinants of effective arterial blood volume in cirrhotic patients. The
effect of head-out water immersion (HWI) in decompensated cirrhotic
patients to correct sodium and water excretion has been found to be
incomplete and variable. The explanation may be that the efficacy of
HWI in correcting a decreased effective arterial blood volume (EABV)
in decompensated cirrhotic patients is limited by an accompanying
decrease in systemic vascular resistance (SVR) and thus a relative
increase in arterial vascular holding capacity. The present studies were
undertaken to examine this possibility by maintaining SVR
(dynes sec cm-5) nearly constant during HWI with an exogenous
infusion of norepinephrine (HWI + NE). In six decompensated cir-
rhotic patients, neither HWI nor NE infusion alone significantly in-
creased sodium excretion (UNaV, 13 vs. 19 and 13 Eq/min, respec-
tively), but each maneuver increased the excretion of a 20 mI/kg water
load (28 to 60 and 61%, respectively, both P < 0.05). The combination
of HWI + NE, however, significantly increased UNaV to 70 Eq/min (P
< 0.05) and percentage of water excretion to 95 (P < 0.001), values
significantly greater than those achieved with either maneuver alone.
These differences were not explained by any changes in inulin clear-
ance. With HWI alone, cardiac index (CI) increased (4.2 to 5.3
liter/min/m2, P < 0.01), but SVR decreased (872 to 613
dynes sec cm5, P < 0.001) and mean arterial pressure (MAP)
remained constant (83 vs. 78 mm Hg). However, with HWI + NE, CI
increased identically (4.2 to 5.3 liter/min/m2, P < 0.001), whereas SVR
fell less (872 to 750 dynes sec cm5, P < 0.05) and therefore MAP
increased (83 to 98 mm Hg, P < 0.01). Thus, decompensated,
hyponatremic cirrhotic patients with ascites demonstrate normal renal
sodium and water excretion in response to increased central blood
volume with concomitant maintenance of SVR. These results are
supportive of a decrease in EABV mediating the sodium and water
retention in decompensated cirrhotic patients.
Interrelation entre le debit cardiaque et les resistances vasculaires
comme determinants du volume sanguin artériel efficace chez des malades
cirrhotiques. L'effet d'une immersion tête sortie (HWI) chez des
malades cirrhotiques dêcompensês afin de corriger l'excrCtion de so-
dium et d'eau a été trouvé incomplet et variable. L'explication pourrait
étre que l'efficacitë d'HWI pour corriger une diminution du volume
sanguin arténel efficace (EABV) chez des malades cirrhotiques
décompensés est limitée par une baisse associée des resistances
vasculaires systémiques (SVR) et done une augmentation relative de Ia
capacité de retention vasculaire artérielle. Ces etudes ont éte
entreprises pour explorer cette possibilité en maintenant SVR
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(dynes sec cm') presque constant au cours d'HWI par une perfu-
sion exogene de noradrénaline (HWI + NE). Chez six cirrhotiques
décompensés, ni HWI ni une perfusion de NE seules n'ont significative-
ment augmente l'excrétion sodée (UNaV, 13 contre 19 et 13 Eq/min,
respectivement) mais chaque manoeuvre a augmentC l'excrétion d'une
charge hydrique de 20 mI/kg (de 28 a 60 et 61%, respectivement,
chacune, P < 0,05). Cependant, l'association d'HWI + NE a accru
significativement UNaV a 70 Eq/min (P < 0,05) et Ic percentage
d'excrétion hydrique a 95 (P < 0,001), des valeurs significativement
plus hautes que celles atteintes lors de chaque manoeuvre seule. Ces
differences n'étaient pas expliquees par un changement de Ia clearance
d l'inuline. Avec l'HWI seule, l'index cardiaque (CI) a augmenté (de 4,2
a 5,3 litre/min/m2, P < 0,01), mais SVR a diminué (de 872 a 613
dynes sec cm5, P < 0,001), et Ia pression artérielle moyenne (MAP)
est restée constante (83 contre 78 mm Hg). Cependant, avec HWI +
NE, CI a augmente de facon identique (de 4,2 a 5,3 litre/min/m2, P <
0,001) tandis que SVR a moms baissé (de 872 a 750 dynes sec cm',
P <0,05) et MAP a done augmente (de 83 a 98mm Hg, P <0,01). Ainsi,
des cirrhotiques dCcompensCs, hyponatrCmiques avec ascite dêmontr-
ent une excretion rénale de sodium et d'eau normale en réponse a une
augmentation du volume sanguin central en maintenant en même temps
SVR. Ces rCsultats sont en faveur d'une diminution d'EABV comme
médiateur de la retention hydro-sodée chez des cirrhotiques
décompensés.
In patients with decompensated cirrhosis and ascites, circu-
lating concentrations of plasma norepinephrine (NE), renin,
aldosterone, and vasopressin (AVP) are elevated [1—4]. These
findings indicate that, even though non-volume factors may
mediate renal sodium retention in the pre-ascitic phase of
cirrhosis [5, 6], a decrease in effective arterial blood volume
(EABV) may be responsible primarily for renal sodium and
water retention in the patient with decompensated cirrhosis
with ascites [7].
The technique of head-out water immersion (HWI) augments
EABV in decompensated cirrhotic patients as assessed by
increased intracardiac pressures and cardiac index [8]. The
maneuver also has been shown to increase renal sodium and
water excretion in association with suppression of plasma
renin, aldosterone, NE, and AVP [8]. However, the response to
HWI has been found to be variable, some patients responding
with a brisk diuresis, others failing to reverse their renal sodium
and water avidity [8, 9].
As systemic vascular resistance (SVR) decreases during HWI
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Table 1. Clinical features of patients
Patient Sex Age Ascites
Peripheral
edema Jaundice
Baseline plasma sodium
mEq/liter
Plasma creatinine
mg/dl
Plasma albumin
gidi
1 M 52 4+ — — 129 0.8 2.2
2 M 31 2+ — + 128 0.9 1.7
3 M 54 2+ 2+ — 131 2.0 3.2
4 F 58 3+ 1+ + 135 1.0 3.8
5 M 52 3+ — + 129 1.0 1.9
6 M 38 2+ 2+ + 130 1.1 2.1
The scale for ascites and peripheral edema is I to 4, with 4 being the most pronounced fluid accumulation.
[8], we proposed that this superimposed vasodilation might act
to attenuate the optimal expansion of EABV in these already
peripherally vasodilated subjects. This fall in SVR could pro-
vide, therefore, an explanation for the incomplete correction of
their renal excretory defects. We evaluated the effect of adding
a vasoconstrictor infusion of NE during HWI, designed to
attenuate this fall in SVR, on renal sodium and water excretion
in patients with decompensated cirrhosis.
Methods
Six patients (five male), aged 31 to 58 years, with alcoholic
cirrhosis were admitted to the Clinical Research Center at the
University of Colorado Health Sciences Center. All patients
manifested excess extracellular sodium and water accumulation
including ascites and hyponatremia (Table 1). All medications
were discontinued 5 days prior to hospital admission. The
patients ingested a 35 mEq sodium diet, but fluid intake was
restricted only if plasma sodium concentration was below 125
mEq/liter. Informed consent was obtained, and the protocol
was approved by the Human Subjects' Committee. The study
was divided into four phases.
Phase 1: Water load
After awakening at 7:00 A.M., all patients voided spontane-
ously. They remained semi-recumbent for the duration of the
study. Intravenous loading doses of para-aminohippuric acid
(PAH, 0.08 mg/kg) and inulin (60 mg/kg) were followed by a
continuous infusion at 30 mI/hr (inulin 60 mg/mI, PAH 0.08
mg/mI). A 20 ml/kg infusion of D5W was given intravenously
over a 30- to 60-mm span. Via an indwelling forearm venous
catheter, hourly blood samples were drawn for estimations of
plasma sodium, potassium, osmolality, glucose, urea, creati-
nine, inulin, PAH, renin, aldosterone, and AVP. The patients
stood briefly to void immediately after each blood sample was
obtained. Each urine sample was analyzed for sodium, potas-
sium, osmolality, urea and creatinine, inulin, and PAH.
Blood pressure was measured every 30 mm using an arm cuff.
Blood and urine collections were continued for a total of 5 hr
after the completion of the water load.
Phase 2: Water load during HWJ
After obtaining the first morning urine, the inulin and PAH
infusions began. The female patient was catheterized. The
patients were lifted in a motorized chair to a temperature-
controlled steel tank containing tap water maintained at 36°C,
and lowered into the water until immersed to the neck while in
a semi-recumbent position as described previously [81. Males
stood briefly to urinate; otherwise, patients remained immersed
for 5 hr after administration of an intravenous water load of 20
ml/kg D5W, as above. Blood and urine samples and blood
pressure measurements were obtained as described in Phase 1.
Phase 3: Water load with NE infusion
In this study, the procedure described in Phase I was
repeated, but with the addition of a continuous intravenous
infusion of NE (16 gIml) immediately after completion of the
water load. The infusion rate was titrated to raise and maintain
mean arterial pressure by 15 to 20 mm Hg above baseline for the
duration of the 5-hr study.
Phase 4: Water load with both HWI and NE (HWI + NE)
infusion with hemodynamic monitoring
In this study, the procedures described in Phases 2 and 3
were combined. In addition, prior to HWI, a Swan-Ganz
thermodilution catheter was inserted via percutaneous puncture
of the median basilic vein in the antecubital fossa. Right atrial
(RAP), pulmonary artery (PAP), and pulmonary wedge (PWP)
pressures were recorded using a transducer (Gould-Statham
P231d, Oxnard, California, USA) and a photographic recorder
(Electronics for Medicine VR 6, White Plains, New York,
USA). Cardiac outputs (CO) were computed using the
thermodilution technique with a computer (Model 9520,
Edwards Laboratories, Santa Ana, California, USA). Values
for cardiac index (CI) and SVR were calculated by standard
formulae:
2 cardiac output (CO)CI (liter/min/m
body surface area
80 (MAP — RAP)SVR (dynes sec • cm ) = _______________CO
Pre-HWI measurements of CO. MAP, RAP, PAP, PWP, and
SVR were obtained in the semi-recumbent position. Then, the
patient was immersed, still in a semi-recumbent position, and
the water load was administered. Hemodynamic measurements
were repeated and after 1 hr of HWI an intravenous infusion of
NE was begun, as in Phase 3. The hemodynamic measurements
at 1 hr after HWI were taken as baseline HWI parameters, as
these have been found previously to remain constant during 5 hr
of HWI [8]. All measurements were repeated hourly. After 5 hr,
the patient was hoisted mechanically from the tank and the
Swan-Ganz catheter was removed.
All four phases were completed within a 2-week period for
each patient randomly. Since each study lasted at least 6 hr, a
light breakfast and midday snack were provided on each
protocol day.
P<0.001
P<0.05
Control NE HWI HWI + NE
Fig. 1. Improved ability to excrete a water load (20 mi/kg) during
head-out water immersion (H WI) and normalization during immersion
with norepinephrine infusion (HWI + NE). Additional abbreviation:
NE, water load during norepinephrine infusion alone.
Biochemical measurements and determinations of renin,
aldosterone, and AVP were performed in our laboratory using
the standard techniques described previously [3, 8].
Statistical analysis utilized two-way analysis of variance for
matched data, using Duncan's method of multiple comparisons,
and least square regression analysis. Results are given as mean
standard error of the mean, A P value of < 0.05 was
considered statistically significant. Values for inulin, creatinine,
and para-aminohippurate clearances, sodium excretion, plasma
hormones, and systemic hemodynamic parameters represent
the mean of the five hourly determinations, unless otherwise
specified.
Results
Five patients completed all four phases of the study protocol.
One patient (Patient #6) completed only Phases 1 and 4, the
latter phase without hemodynamic monitoring. Clinical features
of the patients are shown in Table 1. The NE dose infused in
Phases 3 and 4 of the study was not significantly different (0.112
0.030 vs. 0.125 0.028 xg/kg/min).
Excretion of water load (Figure 1)
HWI significantly improved the percentage of the water load
excreted in each patient from 28.3 6.3 to 60.0 11.1 (P <
0.05). This improvement was similar during NE as the percent
water load excreted increased to 61.0 9.5 (P < 0.05). Neither
of these maneuvers, however, increased the percentage of
water excretion to the level of greater than 80%, which is
observed in normal subjects. However, when HWI was under-
taken in the presence of an exogenous NE infusion to attenuate
a further fall in SVR, the percentage of water excretion in-
creased in each patient to 94.6 9,4 (P < 0.001), a value
significantly greater than with either HWI or NE alone (both P
<0.05).
Excretion of sodium (Figure 2)
HWI increased mean sodium excretion over 5 hr from 12.8
5.6 to 19.2 9.0 Eq/min, but this effect was not statistically
significant. Similarly, NE did not significantly increase sodium
excretion (12.8 5.6 to 13.3 4.1 tEq/min, NS). As with
0r'ii
Control NE HWI HWI + NE
Fig. 2. Immersion with norepinephrine infusion (HWI + NE) reverses
the abnormal renal sodium retention in decompensated cirrhotic pa-
tients. The ordinate on the right represents the projected urinary
sodium excretion (UNaV) in mEq/24 hr based upon the measured UNaV
in sEq/min during the respective 5-hr study period. Abbreviations are:
Control, baseline water load; NE, norepinephrine infusion alone.
water excretion, however, HWI + NE to attenuate a fall in
SVR caused a significant rise in sodium excretion (12.8 5.6 to
69.7 23.8 Eq/min, P < 0.05). Although the degree of
response to HWI + NE was somewhat variable, an increase in
sodium excretion was noted in all of the subjects, and was
significantly greatest with the combined maneuver of HWI +
NE. With the patients on a 35 mEq sodium intake per day, this
rate of sodium excretion during the combined maneuver, if
maintained over a 24-hr period, would equal approximately 100
mEq/day.
Cardiac index and blood pressure (Figures 3—5)
HWI increased CI in each patient from 4.19 0.63 to 5.25
0.73 liter/mm m2, P < 0.01 (Fig. 3). HWI was associated also
with a fall in SVR in each patient from 872 153 to 613 102
100
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Fig. 3. Cardiac index is increased similarly by immersion alone (HWI)
and immersion with norepinephrine infusion (HWI + NE).
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SVR, % increment
Fig. 5. Correlation between the increase in systemic vascular resistance
(SVR) and increase in water load excretion from immersion alone
(HWI) to immersion with norepinephrine infusion (HWI + NE). r =
0.97, P <0.01.
dynes sec cm5, P <0.01, so that mean blood pressure did
not rise (83 3 to 78 3 mm Hg, NS) (Fig. 4). NE significantly
increased mean blood pressure from 83 3 to 98 2 mm Hg,
P < 0.005. HWI during exogenous NE was associated with an
increase in CI in each patient, which was comparable to that
observed with HWI alone (5.31 0.72 and 5.25 0.73
liter/mm m, NS) (Fig. 3). However, the SVR was significantly
higher with HWI + NE as compared to HWI alone (750 124
vs. 613 102 dynes sec cm5, P < 0.05). The comparable CI
and higher SVR led to a significantly higher mean blood
pressure during the HWI + NE than with HWI alone (96 4vs.
78 3 mm Hg, P < 0.001) (Fig. 4). The mean blood pressure
during HWI + NE was, however, no different than with NE
alone (96 4 vs. 98 2 mm Hg, NS), even though sodium and
water excretion was significantly greater during the combined
maneuver.
Although the SVR with HWI + NE was slightly less in each
patient than during the control studies (750 124 vs. 872 153
dynes sec cm5, P < 0.05), the increment in SVR achieved
when comparing HWI to HWI + NE displayed a linear rela-
tionship with the increment in water excretion (r = 0.97, P <
0.01) (Fig. 5).
Right atrial, pulmonary wedge, and mean pulmonary arterial
pressure (Figtire 6)
Measurement of PWP and PAP indicated that HWI effec-
tively increased central blood volume. HWI increased mean
RAP from 6.2 0.8 to 9.8 1.8 mm Hg (P < 0.01), PWP from
6.9 1.1 to 13.1± 1.2 mm Hg (P 0.05) and PAP from 14.5
40 1.7 to 22.0 1.2mm Hg (P < 0.05). The combined maneuver of
HWI + NE was associated with expanded central blood volume
comparable to HWI alone; specifically, mean RAP (9.8 1.8
vs. 10.9 2.3 mm Hg, NS), PWP(13.1 1.2 vs. 13.7 0.9mm
Hg, NS), and PAP (22.0 1.2 vs. 22.7 1.0 mm Hg, NS)
increased by a similar degree in each patient.
Clearance of mu/in, creatinine, and para-aminohippurate
(Table 2)
Any differences in renal water and sodium excretion during
the four phases of the study could not be explained by any
demonstrable differences over the 5-hr study period in mean
glomerular filtration rate, as assessed by inulin and creatinine
clearances, or effective renal plasma flow, as assessed by PAH
clearance. Some variability in the patient's responses, how-
ever, may have precluded a statistically significant change from
occurring.
Plasma hormonal concentrations
The suppression of mean AVP during HWI (1.5 0.3 to 0.7
0.3 pg/mI, P <0.05) was comparable to that with HWI + NE
(1.5 0.3 to 0.8 0.2 pg/ml, P < 0.05). NE alone decreased
plasma AVP (1.5 0.3 to 1.0 0.3 pg/mI), but this decrement
was not statistically significant. Mean plasma renin concentra-
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Fig. 4. Changes in mean arterial pressure (MAP) induced by immersion
alone (HWI) and immersion with norepinephrine infusion (HWI + NE).
The numbers along the abscissa are mean systolic/diastolic blood
pressures during each study condition.
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Fig. 6. Comparable enhancement of intracardiac pressures during
immersion alone (HWI) and immersion with norepinephrine infusion
(HWI + NE). Symbols are: , Baseline (B); U, Head-out water
immersion alone (HWI); , Immersion with norepinephrine infusion
(HWI + NE). a P < 0.05; b, P < 0.01.
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Table 2. Inulin, creatinine, and PAH clearances
Water load HWI NE HWI + NE
C1/1.73 m2, ml/,nin 68.5 12.2 77.2 22.4 79.6 20.9 72.1 18.3
Ccr/1.73 m2, mI/mm 78.0 10.1 79.8 11.1 72.6 9.7 78.4 7.4
CPAH, mI/mm 361.7 61.3 418.9 56.8 423.9 74.5 328.6 63.1
tions were lower with HWI (5.1 1.9 ng/ml/hr) as compared to
control (5.9 2.5 nglml/hr) or with NE (5.2 2.1 ngfml/hr), but
these values were not significantly different. However, the
lowest plasma renin values (3.6 1.7 ng/mllhr, P < 0.01)
occurred during HWI + NE. Plasma aldosterone concentra-
tions were also lowest during HWI + NE (32.6 9.8 ng!dl, P <
0.05) as compared to baseline (58.0 17.0 ng/dl). HWI alone
produced a suppression of plasma aldosterone (43.8 16.1
ng/dl), which did not reach statistical significance.
Discussion
Cirrhosis develops over a period of years and thus the
accompanying hemodynamic consequences and mechanisms of
renal sodium and water retention may vary between the early
and later stages of the disease. For example, the progression of
portal hypertension causes engorgement and expansion of the
holding capacity of the mesenteric circulation as well as open-
ing portal systemic venous collaterals. Logically, these effects
may cause the increase in plasma volume that occurs in the
earlier stages of cirrhosis. This splanchnic engorgement may be
associated; therefore, with renal sodium retention in the ab-
sence of any evidence of a decrease in EABV. An increase in
intrahepatic pressure has been another non-volume factor that
has been suggested to be a factor in the pre-ascitic sodium
retention associated with cirrhosis [5, 61.
In the later, decompensated stages of cirrhosis, there is
evidence of a decrease in EABV [7]. Since the patient's history
and routine liver function tests may be inadequate to document
the stage of cirrhosis, most studies have examined the renal
responses of unselected, potentially heterogeneous groups of
cirrhotic patients. In this regard, the maneuver of HWI has
been shown to be associated with an exaggerated natriuresis,
normal natriuresis, and impaired sodium excretion in a group of
unselected patients with cirrhosis [9].
In our recent laboratory studies, we have used an acute water
load (20 mI/kg) to categorize cirrhotic patients into excretors (>
80% excreted over 5 hr) and non-excretors (< 80% excreted
over 5 hr). Compared to the excretor patients, the non-excretor
patients with cirrhosis exhibit evidence of a decrease in EABV,
as suggested by significantly higher plasma concentrations of
renin, aldosterone, NE, and AVP [3]. The non-excretor patients
were more hyponatremic, hypoalbuminemic, and tachycardic.
On comparable sodium intake, the non-excretor patients exhib-
ited more avid renal sodium retention and more clinical evi-
dence of ascites (100% of the non-excretors versus 28% of the
excretors).
In a subsequent study, a group of non-excretor patients
underwent HWI to examine the role of a decrease in EABV as
an important afferent stimulus for renal water and sodium
excretion [8]. During HWI these decompensated patients de-
creased their plasma concentrations of renin, aldosterone, NE,
and AVP. Moreover, as in the present study, in these non-
excretor patients, the previously reported heterogeneity in
renal response to HWI [91 was not observed; specifically, none
of the patients exhibited an exaggerated or even normal re-
sponse to HWI. When the non-excretor patient's renal sodium
and water excretion was compared with and without HWI,
evidence for an incomplete restoration of EABV was obtained
since improved, but not normal, urinary excretion rates were
observed [8]. In a more recent analysis, those non-excretor
patients with the most tense ascites and diuretic resistance
demonstrated the most impaired renal response to HWI [10].
The present study examines the role of peripheral vascular
resistance in the decrease in EABV in decompensated cirrhotic
patients (non-excretors). While we have shown that HWI
increases intracardiac pressures and cardiac indices in non-
excretor patients, systemic vascular resistance diminishes dur-
ing HWI [8]. As reported previously [11—141, patients with
decompensated cirrhosis exhibit low peripheral vascular resist-
ance frequently. This abnormality, whether due to increased
arteriovenous shunting, increased splanchnic arterial flow, hu-
moral consequences, or a combination thereof, is worsened
with HWI. In this study, the fall in peripheral vascular resist-
ance was attenuated by an exogenous infusion of NE.
When these non-excretor patients were studied as their own
controls in a random order (HWI compared to HWI + NE) the
results were highly significant. Moreover, the rates of sodium
and water excretion increased to the normal range during the
combined maneuver. HWI and HWI + NE increased cardiac
indices to the same degree; this was probably due to counter-
balancing effects of NE to increase both the afterload and
ionotropic effects on the heart. With a similar mean rise in
cardiac index and less of a fall in peripheral vascular resistance,
the combined maneuver was associated with a significantly
higher mean arterial pressure. It is important to emphasize,
however, that blood pressure in these cirrhotic patients was
only brought into the normal range for age-matched individuals
(136/76 mm Hg). Thus, a pressure diuresis should not be
implicated as obscuring other pathological factors causing so-
dium and water retention in these cirrhotic patients. This is,
however, a potential criticism of studies of cirrhotic patients in
which pressor agents have been infused to raise blood pressure
into the hypertensive range [15, 16].
The increase in systemic and renal arterial pressure was,
however, not the sole explanation for the profound effect on
renal sodium and water excretion in these decompensated
patients, since NE without HWI caused a similar rise in blood
pressure and yet a much less dramatic effect on renal sodium
and water excretion.
Although the efferent limb of the sodium and water retention
was not the primary focus of this study, some tentative conclu-
sions can be made. The normal response of renal water excre-
tion to the combined maneuver appears to be both AVP and
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non-AVP mediated. HWI and HWI + NE suppressed plasma
AVP in decompensated cirrhotic patients (vida supra, present
study), to a comparable degree; therefore, the greater water
excretion with the combined maneuver must have involved
both increased distal fluid delivery and suppression of AVP
release. With respect to renal sodium excretion, plasma renin
and aldosterone were more significantly suppressed with the
combined maneuver; moreover, escape from the sodium-
retaining effect of aldosterone would be expected to be en-
hanced by the increased distal fluid and sodium delivery which
occurred most likely with the combined maneuver. Although
not evaluated in this study, in addition to the increased renal
perfusion pressure, release of atrial natriuretic factor [17]
during central blood volume expansion could be involved also
in the improved natriuretic and diuretic response to the com-
bined maneuver.
Taken together, therefore, the present results indicate that a
decrease in EABV in decompensated cirrhotic patients pro-
vides a profound stimulus for sodium and water retention. In
these patients with decompensated cirrhosis and diminished
peripheral vascular resistance, a combination of central blood
volume expansion with HWI and maintenance of peripheral
vascular resistance with NE is significantly more effective in
reversing the defect in renal sodium and water excretion than
HWI alone., Therefore, in decompensated cirrhotic patients
with ascites, the decrease in systemic vascular resistance that
accompanies HWI may be preventing an already inadequate
cirrhotic circulation from the otherwise potentially beneficial
effects of HWI-induced increases in central blood volume.
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